FDA Panel Backs Sunitinib for Pancreatic Neuroendocrine Tumors April 12, 2011GastroenterologyGastrointestinal Cancer
Panel Backs Everolimus for Pancreatic Neuroendocrine TumorsApril 12, 2011GastroenterologyGastrointestinal Cancer
Stomach, Esophageal Cancer Risks Increased in AIDS PatientsApril 12, 2011GastroenterologyPreventive CareGastrointestinal Cancer
Adherence to Treatment Guidelines Varies Widely in Colon CancerApril 7, 2011GastroenterologyGastrointestinal Cancer
New Formula Gauges Disease-Free Colorectal SurvivalApril 5, 2011GastroenterologyPatient & Survivor CareGastrointestinal Cancer
Lag in Preop Imaging Problematic in Pancreatic Cancer PatientsApril 1, 2011GastroenterologyGastrointestinal Cancer
Molecular Markers Predict Need For Adjuvant Treatment of Colon CancerMarch 1, 2011GastroenterologyGastrointestinal Cancer
Bevacizumab Fails to Improve 3-Year Survival in Early Colon CancerJune 1, 2009GastroenterologyGastrointestinal Cancer
